Amanda Ruci is a Co-Founder of DioTeX Diagnostics, where she leads innovation in developing point-of-care technologies for early detection of internal hemorrhage. She is an inventor on a U.S. patent for biomarker detection and has secured funding through innovation competitions and completion of the NSF I-Corps regional program